1. Home
  2. Disease & Disorders
  3. Bethesda, MD
  4. Fibrous Dysplasia Foundation

Fibrous Dysplasia Foundation

Fibrous Dysplasia Foundation has an America's Best Score of 29 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • Bethesda, MD
  • Tax-exempt since 2005
  • EIN: 02-0715210
fdmasalliance.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
29OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Fibrous Dysplasia Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G99). Contributions are tax-deductible.

7315 Wisconsin Ave, Bethesda, MD 20814-3202

Among the 8 scored disease & disorders organizations in Bethesda, Fibrous Dysplasia Foundation holds 0.3 months of operating reserves (peer median 11.9 months), runs a typical yearly deficit of 16.8% (peers: deficit of 0.1%), and has cut spending 15.5% a year (peers: grown spending 4.3% a year).

In fiscal year 2025 it reported $245,764 in revenue and $270,098 in expenses, with contributions making up 97.2% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The Fibrous Dysplasia Foundation serves people affected with fibrous dysplasia/mccune-albright syndrome through programs of research, education, awareness and support.

Largest programs · fiscal year 2025

  • Research programs: -In 2025, team fd/mas awarded two research grants totaling over 120,000 to advance fd/mas specific research: --Dr. Ariane zamarioli of ribeirao preto medical school received 40,234.00 for her project elucidating a link between microfractures and fibrous dysplasia bone pain in mice. --Dr. J. Silvio gutkind of the university of California, san diego, received 80,468.00 for his pro… Read more

    Research programs: -In 2025, team fd/mas awarded two research grants totaling over 120,000 to advance fd/mas specific research: --Dr. Ariane zamarioli of ribeirao preto medical school received 40,234.00 for her project elucidating a link between microfractures and fibrous dysplasia bone pain in mice. --Dr. J. Silvio gutkind of the university of California, san diego, received 80,468.00 for his project targeting gnas-driven pathway for precision therapy of fibrous dysplasia. -Hosted two research updates --dr. Marc wein of mass general hospital shared findings from his prmrp- funded project, focusing on therapeutic concepts that have emerged from his basic science studies. --In June, alison boyce shared research updates from her phase two clinical trial of burosumab, which helps regulate phosphate levels -support and maintenance of the fd/mas patient registry, an irb-approved study.

    $74,265 spent · 37.0% of program spending
  • Advocacy programs: -Alliance advocates secured another year of access to the peer-reviewed medical research program (prmrp) and 150 million of possible research funds -adrienne mcbride sat on the global genes corporate alliance committee that developed a new white paper, "early and often: Reimagining patient community engagement to improve clinical trials feasibility," which shows the transformati… Read more

    Advocacy programs: -Alliance advocates secured another year of access to the peer-reviewed medical research program (prmrp) and 150 million of possible research funds -adrienne mcbride sat on the global genes corporate alliance committee that developed a new white paper, "early and often: Reimagining patient community engagement to improve clinical trials feasibility," which shows the transformative role of patient advocacy organizations in rare disease drug development. -Faces of fd/mas is an fd/mas alliance video project envisioned and guided by the patient advisory council (pac). The project aims to capture the diverse experiences of those in the fibrous dysplasia, mccune-albright syndrome (fd/mas) community. Videos were released throughout 2024 and 2025.

    $56,200 spent · 28.0% of program spending
  • Education program: -We empower the fd/mas community with the best educational resources and share these resources on the fd/mas alliance's website and youtube channel. We produce and share educational webinars for patients and caregivers." -monthly web programming, designed and hosted by fd/mas alliances patient advisory council, offers an opportunity for patients and caregivers to connect, share… Read more

    Education program: -We empower the fd/mas community with the best educational resources and share these resources on the fd/mas alliance's website and youtube channel. We produce and share educational webinars for patients and caregivers." -monthly web programming, designed and hosted by fd/mas alliances patient advisory council, offers an opportunity for patients and caregivers to connect, share experiences, and ask questions in a safe and supportive space. This year, programs covered topics focused on quality of life as well as medical and educational programming: Living independently with fd/mas navigating relationships with fd/mas encouraging self-advocacy tools for tough times clinical trials 101 psychology in pediatric care

    $54,193 spent · 27.0% of program spending
  • Fd/mas alliance, in addition to its other program services: - Maintains a comprehensive, up-to-date repository of information for patients, caregivers, and medical practitioners, including recent research publications, diagnosis and treatment guidelines, relevant funding opportunities for basic and clinical investigators, and information on ongoing clinical trials in fd/mas. - Expands and strength… Read more

    Fd/mas alliance, in addition to its other program services: - Maintains a comprehensive, up-to-date repository of information for patients, caregivers, and medical practitioners, including recent research publications, diagnosis and treatment guidelines, relevant funding opportunities for basic and clinical investigators, and information on ongoing clinical trials in fd/mas. - Expands and strengthens the network of fd/mas researchers and patient advocates worldwide through education, communications, and alliance- building initiatives, including a biennial conference. - Remotely attends or, when suitable, travels to both domestic and international scientific gatherings to advocate for fd/mas research opportunities to broaden the network of involved researchers and other stakeholders working on potential therapies. - Provides mentoring and community building among other fd/mas patient organizations to enhance the effectiveness and coordination of these groups worldwide.

    $16,057 spent · 8.0% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 74¢ went to programs, 18¢ to management and 8¢ to fundraising.

  • Programs $200,715
  • Management $47,976
  • Fundraising $21,407

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score29 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves0.3 mo; 10.5 mo in cash0.2 / 25
Financial balance (median margin)−16.8%0.4 / 20
Transparency3 full 990s, latest TY202520 / 20
Program growth−15.5% / yr0 / 15
Track record21 years8.4 / 10
Debt load97.6% of assets0 / 10
Total29 → 29
Spending on programs
Not scored; America's Best needs 65%+
74%Meets

Compared with Bethesda peers

MeasureThis organizationPeer median
Operating reserves0.3 mo11.9 mo
Typical margin−16.8%−0.1%
Spending growth−15.5% / yr+4.3% / yr
Debt load97.6%8.1%

Peers: the 8 Bethesda disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$245,764Fiscal year 20252023: $282,76820232024: $322,94220242025: $245,7642025
Expenses$270,098Fiscal year 20252023: $377,90920232024: $388,13820242025: $270,0982025
Total assets$243,546Fiscal year 20252023: $329,39920232024: $267,36420242025: $243,5462025
Total liabilities$237,726Fiscal year 20252023: $234,04920232024: $237,21020242025: $237,7262025
Fiscal year ending June 2025
Revenue$245,764
Expenses$270,098
Net income−$24,334
Net assets$5,820

Notable sources of revenue

Percent of total revenue
Contributions$238,806
Program services$0
Investment income$6,958
Other (net)$0

Assets / debt

Total assets$243,546
Total liabilities$237,726
Net assets$5,820

Compensation

Not in our extract for this year.

Fiscal year ending June 2024
Revenue$322,942
Expenses$388,138
Net income−$65,196
Net assets$30,154

Notable sources of revenue

Percent of total revenue
Contributions$317,260
Program services$0
Investment income$5,682
Other (net)$0

Assets / debt

Total assets$267,364
Total liabilities$237,210
Net assets$30,154

Compensation

Officers and key employees$84,011
Share of expenses21.6%
Fiscal year ending June 2023
Revenue$282,768
Expenses$377,909
Net income−$95,141
Net assets$95,350

Notable sources of revenue

Percent of total revenue
Contributions$282,634
Program services$0
Investment income$134
Other (net)$0

Assets / debt

Total assets$329,399
Total liabilities$234,049
Net assets$95,350

Compensation

Officers and key employees$84,976
Share of expenses22.5%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?